Industries

Industries

Inside the CPO Agenda – Technology, Media & Telecommunica...

This article is part of Inverto’s Inside the CPO Agenda series, which supplements findings from the broader CPO Survey through in-depth qualitative interviews. The highlighted case study features a leading global technology and telecommunications com...

Industries

Maximizing Value Through Post-Merger Integration Excellence

From due diligence to Day One and beyond, transform integration into measurable value — fast, focused, and built to last.

Industries

Supplier & Vendor Evaluation: Why One-Off Ratings Miss th...

Why supplier and vendor performance must be managed continuously - not just evaluated once – and how

Industries

Inside the CPO Agenda: Consumer

This article is part of Inverto's Inside the CPO Agenda series, which supplements findings from the broader CPO Survey through in-depth qualitative interviews. The highlighted case study comes from a global consumer goods company transforming its pro...

Industries

Procurement SCM Trends Energy 2025

Procurement will be at the heart of the energy transition, tackling infrastructure constraints, supply chain resilience, and shifting policies while leveraging AI and strategic sourcing to drive value.

Industries

Private Equity’s Edge: Using GenAI and Procurement to Unlock V...

Discover how private equity leaders are moving beyond traditional cost-cutting. With Inverto’s GenAI-powered procurement strategies, firms achieve fast measurable impact — unlocking transparency, collaboration, and 20–30% savings that sustain long-te...

Industries

From Cost Pressure to Strategic Advantage

In this exclusive interview, Matthew Rose (TMT) and José Carande Morgado (Banking) reveal how procurement is evolving from a cost enforcer to a true strategic partner in two of the world’s most dynamic sectors.

Industries

Beyond the Price Tag

Inflation, shifting consumer expectations, and ongoing supply chain disruptions are reshaping the role of private label in food retail.

Industries

The New Cost Excellence Imperative

Innovation remains non-negotiable in pharmaceutical R&D – but so does cost discipline. With longer innovation cycles, tightening budgets, and increasingly complex supplier ecosystems, traditional ways of managing R&D expenses are no longer sustainabl...

Industries

Cracking the Cost+ Code

Cost+ contracts are gaining traction in the energy sector as a flexible solution for high-risk, high-stakes projects. But without the right governance, transparency, and collaboration, they can quickly spiral into inefficiency and overspend.